Fox, S., Generali, D., Berruti, A., Brizzi, M., Campo, L., Bonardi, S., . . . Harris, A. (2011). The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
Chicago-referens (17:e uppl.)Fox, S., et al. The Prolyl Hydroxylase Enzymes Are Positively Associated with Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor in Human Breast Cancer and Alter in Response to Primary Systemic Treatment with Epirubicin and Tamoxifen. 2011.
MLA-referens (9:e uppl.)Fox, S., et al. The Prolyl Hydroxylase Enzymes Are Positively Associated with Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor in Human Breast Cancer and Alter in Response to Primary Systemic Treatment with Epirubicin and Tamoxifen. 2011.